02269 WUXI BIO
Closed Add to PorfolioIndex Constituent : Hang Seng Index, HS Composite Index, HS Comp.LargeCap Ind, HS Comp. L & M Index, HS HK 35, Stock Connect HK Ind | |||
Major Shareholders | Li Ge & Associates (13.84%) BlackRock, Inc. (5.21%) |
Sector | Health Care & Biotechnology |
---|---|---|---|
Web Site | http://www.wuxibiologics.com | Tel | N/A |
Info@wuxibiologics.com | Fax | N/A | |
Related Equities | N/A | ||
Principal Activities | The Group is principally engaged in the provision of end-to-end solutions and services for biologics discovery, development and manufacturing to customers involving in biologics industry. |
Consolidated List of Substantial Shareholders
Name | Number of Shares Interested | % of Issued Share Capital (%) | Date of Last Notice Filed (Y/M/D) |
---|---|---|---|
劉曉鐘 | 724,935,597(L) | 59.20(L) | 22/06/2018 |
張朝暉 | 724,935,597(L) | 59.20(L) | 22/06/2018 |
李革 | 724,935,597(L) | 59.20(L) | 22/06/2018 |
趙寧 | 724,935,597(L) | 59.20(L) | 22/06/2018 |
New WuXi Life Science Holdings Limited | 676,380,917(L) | 55.24(L) | 22/06/2018 |
JPMorgan Chase & Co. | 61,952,334(L) 3,730,884(S) 38,416,948(P) | 5.05(L) 0.30(S) 3.13(P) | 14/01/2019 |
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Complete List of Directors
Director's Name | Number of Shares Interested | % of issued share capital (%) | Date of Last Notice Filed (Y/M/D) |
---|---|---|---|
周偉昌 | 5,931,000(L) | 0.51(L) | 12/01/2018 |
Last Update : 2019-02-28
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool